Electromed (ELMD) Free Cash Flow Growth (5y) (2015 - 2026)
Electromed (ELMD) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn |
| 10 | Electromed | 329.43 Mn | 312.45 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.60% |
| Dec 31, 2025 | 31.06% |
| Sep 30, 2025 | -16.68% |
| Jun 30, 2025 | 26.54% |
| Mar 31, 2025 | 22.55% |
| Dec 31, 2024 | 20.90% |
| Sep 30, 2024 | 58.90% |
| Jun 30, 2024 | 73.83% |
| Mar 31, 2024 | 40.19% |
| Dec 31, 2023 | 52.98% |
| Sep 30, 2023 | -26.25% |
| Jun 30, 2023 | 6.19% |
| Mar 31, 2023 | -10.11% |
| Dec 31, 2022 | -2.99% |
| Sep 30, 2022 | -59.43% |
| Jun 30, 2022 | -52.16% |
| Mar 31, 2022 | -20.20% |
| Dec 31, 2021 | -29.24% |
| Sep 30, 2021 | 8.74% |
| Jun 30, 2021 | 21.19% |